May 2, 2018 / 12:36 AM / 3 months ago

BRIEF-Mayne Pharma's NDA For Suba-Itraconazole Capsules Accepted For Review By U.S. FDA

May 2 (Reuters) - Mayne Pharma Group Ltd:

* NEW DRUG APPLICATION FOR SUBA-ITRACONAZOLE CAPSULES ACCEPTED FOR REVIEW BY U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below